At Polpharma Biologics, our commitment to excellence begins at the top.
With decades of combined experience in the development, manufacture and commercialization of biopharmaceuticals, our international management team brings both knowledge and passion to every project.
Polpharma Biologics Group BV
Jerzy Starak is the founder and Chairman of Polpharma Biologics Group B.V. Mr Starak is an investor in the pharma, biotech, consumer goods and real estate sectors across Europe and is a visionary, who does not lack the courage, determination and perseverance in taking on ambitious challenges.
Hannes is a Vice Chairman of Polpharma Biologics B.V., a company which he was instrumental in establishing over the last 7 years. Hannes is a seasoned biopharmaceutical executive with a track record in general management, business turnaround, finance, business development and M&A.
Dr. Joerg Windisch, President & CEO of Polpharma Biologics Group B.V., has around 25 years of experience in the development, manufacture and regulatory licensure of biologic therapies. Prior to joining Polpharma Biologics, Dr. Windisch served as the Chief Operating Officer (COO) for Affimed. Before that, Dr. Windisch spent almost 20 years at Novartis/Sandoz where he most recently served as CSO for Sandoz Biopharmaceuticals. He was a key figure in developing the first biosimilars approved in Europe and the US.